Idexx Laboratories Company Profile (NASDAQ:IDXX)

About Idexx Laboratories

Idexx Laboratories logoIDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company's segments include Companion Animal Group (CAG), which develops, designs, manufactures and distributes products and performs services for veterinarians and the bioresearch market; Water, which develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water; Livestock, Poultry and Dairy (LPD), which develops, designs, manufactures and distributes diagnostic tests and related instrumentation, and performs services that are used to manage the health status of livestock and poultry and to expand bovine reproductive productivity, and Other, which develops, designs, manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: IDXX
  • CUSIP: 45168D10
Key Metrics:
  • Previous Close: $111.36
  • 50 Day Moving Average: $111.18
  • 200 Day Moving Average: $92.74
  • 52-Week Range: $89,540,000.00 - $63.48
  • Trailing P/E Ratio: 50.48
  • Foreward P/E Ratio: 41.55
  • P/E Growth: 3.45
  • Market Cap: $9.97B
  • Outstanding Shares: 89,540,000
  • Beta: 0.56
  • Net Margins: 11.94%
  • Return on Equity: -414.67%
  • Return on Assets: 14.36%
  • Debt-to-Equity Ratio: -70.43%
  • Current Ratio: 1.00%
  • Quick Ratio: 0.78%
Additional Links:
Companies Related to Idexx Laboratories:

Analyst Ratings

Consensus Ratings for Idexx Laboratories (NASDAQ:IDXX) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $101.25 (9.08% downside)

Analysts' Ratings History for Idexx Laboratories (NASDAQ:IDXX)
DateFirmActionRatingPrice TargetDetails
8/22/2016Canaccord GenuityReiterated RatingBuy$120.00View Rating Details
8/16/2016Stifel NicolausBoost Price TargetBuy$120.00 -> $125.00View Rating Details
8/3/2016Northcoast ResearchUpgradeSell -> NeutralView Rating Details
4/13/2016Credit Suisse Group AGBoost Price TargetOutperform$80.00 -> $85.00View Rating Details
4/1/2016CL KingInitiated CoverageNeutralView Rating Details
2/1/2016Piper Jaffray Cos.Reiterated RatingNeutral$73.00 -> $75.00View Rating Details
1/31/2016William BlairReiterated RatingOutperformView Rating Details
8/28/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
7/23/2015Feltl & Co.UpgradeSell -> Hold$61.50 -> $69.50View Rating Details
5/28/2015Bank of America Corp.Reiterated RatingBuy$168.00View Rating Details
(Data available from 9/26/2014 forward)


Earnings History for Idexx Laboratories (NASDAQ:IDXX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$0.62$0.74$444.83 million$467.00 millionViewListenView Earnings Details
4/29/2016Q116$0.47$0.51$403.48 million$417.55 millionViewListenView Earnings Details
1/29/2016Q415$0.44$0.48$397.39 million$400.00 millionViewListenView Earnings Details
10/28/2015Q315$0.53$0.54$409.33 million$406.00 millionViewListenView Earnings Details
7/30/2015Q215$0.57$0.60$412.57 million$413.30 millionViewListenView Earnings Details
4/28/2015Q115$0.99$0.98$394.38 million$382.00 millionViewN/AView Earnings Details
1/30/2015Q414$0.80$0.54$373.20 million$352.00 millionViewN/AView Earnings Details
10/24/2014Q314$0.90$1.05$371.80 million$384.00 millionViewListenView Earnings Details
7/25/2014Q214$1.05$1.10$385.20 million$390.00 millionViewN/AView Earnings Details
4/25/2014Q114$0.87$0.89$361.58 million$360.20 millionViewListenView Earnings Details
2/4/2014Q413$0.81$0.82$347.08 million$354.10 millionViewN/AView Earnings Details
10/22/2013Q313$0.83$0.86$339.70 million$338.30 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.97$0.99$356.80 million$352.60 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.83$0.81$341.06 million$332.10 millionViewN/AView Earnings Details
1/29/2013Q4 2012$0.71$0.78$325.10 million$319.50 millionViewN/AView Earnings Details
10/19/2012$0.73$0.76ViewN/AView Earnings Details
7/20/2012$0.90$0.91ViewN/AView Earnings Details
4/20/2012$0.71$0.72ViewN/AView Earnings Details
1/27/2012$0.63$0.67ViewN/AView Earnings Details
10/21/2011$0.65$0.66ViewN/AView Earnings Details
7/22/2011$0.72$0.83ViewN/AView Earnings Details
4/21/2011$0.59$0.62ViewN/AView Earnings Details
1/28/2011$0.55$0.62ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Idexx Laboratories (NASDAQ:IDXX)
Current Year EPS Consensus Estimate: $2.36 EPS
Next Year EPS Consensus Estimate: $2.68 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.46$0.47$0.47
Q2 20163$0.62$0.63$0.63
Q3 20163$0.58$0.62$0.60
Q4 20163$0.49$0.54$0.51
Q1 20171$0.58$0.58$0.58
Q2 20171$0.88$0.88$0.88
Q3 20171$0.69$0.69$0.69
Q4 20171$0.55$0.55$0.55
(Data provided by Zacks Investment Research)


Dividend History for Idexx Laboratories (NASDAQ:IDXX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Idexx Laboratories (NASDAQ:IDXX)
Insider Ownership Percentage: 2.79%
Institutional Ownership Percentage: 91.58%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/25/2016Rebecca M HendersonDirectorSell9,924$110.43$1,095,907.32View SEC Filing  
8/15/2016Barry C JohnsonDirectorSell9,924$111.37$1,105,235.88View SEC Filing  
8/8/2016Michael J. Phd WilliamsInsiderSell49,560$108.94$5,399,066.40View SEC Filing  
8/5/2016William T EndDirectorSell5,000$108.50$542,500.00View SEC Filing  
8/4/2016Jonathan W. AyersChairmanSell60,000$107.69$6,461,400.00View SEC Filing  
5/5/2016William T EndDirectorSell4,924$85.87$422,823.88View SEC Filing  
2/24/2016Michael J Phd WilliamsEVPSell2,000$71.93$143,860.00View SEC Filing  
2/9/2016Thomas CraigDirectorSell2,054$69.52$142,794.08View SEC Filing  
2/8/2016Brian P. MckeonCFOSell9,054$69.65$630,611.10View SEC Filing  
11/30/2015Thomas CraigDirectorSell7,000$70.28$491,960.00View SEC Filing  
11/12/2015Rebecca M. HendersonDirectorSell2,300$68.39$157,297.00View SEC Filing  
8/31/2015Thomas CraigDirectorSell800$71.77$57,416.00View SEC Filing  
8/18/2015Michael J. Phd WilliamsEVPSell6,586$78.34$515,947.24View SEC Filing  
8/18/2015Thomas CraigDirectorSell2,900$79.41$230,289.00View SEC Filing  
8/17/2015Jonathan W AyersCEOSell14,799$78.45$1,160,981.55View SEC Filing  
5/18/2015William T EndDirectorSell3,527$134.51$474,416.77View SEC Filing  
3/10/2015William T EndDirectorSell3,500$150.89$528,115.00View SEC Filing  
3/4/2015Johnny D PowersEVPSell6,168$158.49$977,566.32View SEC Filing  
2/17/2015Brian P MckeonCFOSell5,000$156.99$784,950.00View SEC Filing  
2/12/2015Jonathan W AyersCEOSell58,245$155.45$9,054,185.25View SEC Filing  
2/5/2015Rebecca M HendersonDirectorSell2,934$156.27$458,496.18View SEC Filing  
2/4/2015Thomas CraigDirectorSell2,200$157.02$345,444.00View SEC Filing  
1/14/2015Jonathan W AyersCEOSell28,512$157.68$4,495,772.16View SEC Filing  
12/3/2014Jonathan W AyersCEOSell29,000$148.49$4,306,210.00View SEC Filing  
11/13/2014Thomas CraigDirectorSell5,000$152.45$762,250.00View SEC Filing  
11/5/2014Jonathan W AyersCEOSell29,000$143.45$4,160,050.00View SEC Filing  
11/4/2014Johnny D PowersEVPSell1,292$142.70$184,368.40View SEC Filing  
8/13/2014M Anne SzostakDirectorBuy2,000$127.03$254,060.00View SEC Filing  
2/20/2014M Anne SzostakDirectorBuy2,000$126.71$253,420.00View SEC Filing  
2/19/2014Thomas CraigDirectorSell4,800$125.42$602,016.00View SEC Filing  
2/3/2014Jonathan AyersCEOSell81,294$112.46$9,142,323.24View SEC Filing  
11/26/2013Jonathan AyersCEOSell78,178$105.29$8,231,361.62View SEC Filing  
11/22/2013Sophie VandebroekDirectorBuy1,000$107.84$107,840.00View SEC Filing  
11/13/2013Jonathan AyersCEOSell78,178$106.36$8,315,012.08View SEC Filing  
11/4/2013M Anne SzostakDirectorBuy1,000$108.24$108,240.00View SEC Filing  
11/4/2013Michael Phd WilliamsEVPSell6,020$108.19$651,303.80View SEC Filing  
10/31/2013William T EndDirectorSell2,500$108.32$270,800.00View SEC Filing  
10/25/2013Jonathan W AyersCEOSell78,178$104.36$8,158,656.08View SEC Filing  
9/13/2013Johnny PowersEVPSell13,128$96.59$1,268,033.52View SEC Filing  
9/5/2013Michael J Phd WilliamsEVPSell5,162$95.58$493,383.96View SEC Filing  
5/9/2013Ali NaquiVPSell12,961$87.00$1,127,607.00View SEC Filing  
2/4/2013Merilee RainesCFOSell175,929$94.25$16,581,308.25View SEC Filing  
11/13/2012Jonathan W AyersCEOSell15,000$89.92$1,348,800.00View SEC Filing  
9/5/2012Johnny D PowersEVPSell4,000$97.12$388,480.00View SEC Filing  
8/8/2012Merilee RainesCFOSell7,726$88.84$686,377.84View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Idexx Laboratories (NASDAQ:IDXX)
DateHeadline logoFirst Week of IDXX November 18th Options Trading (NASDAQ:IDXX) - September 23 at 5:13 PM logoBaron Asset Fund Position In IDEXX Laboratories, Inc (NASDAQ:IDXX) - September 23 at 5:13 PM logoWhat's Going on at Idexx Laboratories? (NASDAQ:IDXX) - September 21 at 4:39 PM logoIdexx Laboratories Shares Up 55.8% Since SmarTrend's Buy Recommendation (IDXX) (NASDAQ:IDXX) - September 21 at 9:46 AM logoMDY, WWAV, IDXX, COO: Large Outflows Detected at ETF - Nasdaq (NASDAQ:IDXX) - September 20 at 10:42 AM
News IconStock Update: Estimates & Target in Focus for IDEXX Laboratories ... - Frisco Fastball (NASDAQ:IDXX) - September 20 at 10:42 AM logoMDY, WWAV, IDXX, COO: Large Outflows Detected at ETF (NASDAQ:IDXX) - September 19 at 5:38 PM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Accounts Payable Is $50.085 - (NASDAQ:IDXX) - September 17 at 5:16 PM
News IconHow has IDEXX Laboratories, Inc.:(NASDAQ:IDXX) performed recently? - The Daily Leicester (NASDAQ:IDXX) - September 17 at 5:16 PM
News IconA look at a High Market Cap Stock: IDEXX Laboratories, Inc., IDXX ... - The Daily Leicester (NASDAQ:IDXX) - September 14 at 5:41 PM logoShares of IDXX Up 52.6% Since Uptrend Call on Shares (NASDAQ:IDXX) - September 14 at 9:48 AM logoResearch Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX)’s Price Target At $100.75 (NASDAQ:IDXX) - September 13 at 10:24 AM logoAcadia & Ochsner Form Partnership, Announce New Facility (NASDAQ:IDXX) - September 13 at 10:24 AM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX) from Diagnostic Substances – Todays Top Gains (NASDAQ:IDXX) - September 12 at 10:16 AM logoWhy Did Valspar’s Coatings Segment Revenue Fall in 3Q16? (NASDAQ:IDXX) - September 12 at 10:16 AM
News IconStock Valuation Recap for IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Post News (NASDAQ:IDXX) - September 10 at 5:07 PM
News IconLong Term Growth Stock in Review: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - National Daily Press (NASDAQ:IDXX) - September 10 at 5:07 PM
News IconIs IDEXX Laboratories, Inc.(NASDAQ: IDXX), a large market cap ... - The Daily Leicester (NASDAQ:IDXX) - September 10 at 5:07 PM
News IconToday's Top Gainers in the Market IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Healthcare - The Daily Leicester (NASDAQ:IDXX) - September 9 at 10:17 AM
News IconStock Trading Above Moving Averages: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Post News (NASDAQ:IDXX) - September 8 at 9:29 AM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX): What is the Sell-side Making of this Stock? - Post News (NASDAQ:IDXX) - September 8 at 9:29 AM
News IconUpdate on IDEXX Laboratories, Inc. (NASDAQ:IDXX) for the day (NASDAQ:IDXX) - September 7 at 5:44 PM logoIDEXX Laboratories to Present at Raymond James North American Equities Conference (NASDAQ:IDXX) - September 6 at 5:33 PM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX) – Top Stock from ... - The Daily Leicester (NASDAQ:IDXX) - September 5 at 5:01 PM logoAccounts Payable For IDEXX Laboratories, Inc. (NASDAQ:IDXX) Is ... - (NASDAQ:IDXX) - September 3 at 5:02 PM
News IconIs IDEXX Laboratories, Inc. (NASDAQ:IDXX), a large market cap stock a smart buy? (NASDAQ:IDXX) - September 1 at 5:27 PM logoWhat's the Prognosis for This Pet Health Stock? (NASDAQ:IDXX) - September 1 at 5:27 PM logoWhy IDEXX Laboratories (IDXX) is Poised to Beat Earnings Estimates (Again) (NASDAQ:IDXX) - September 1 at 8:33 AM logoThermo Fisher Closes FEI Deal, Grows in Electron Microscopy (NASDAQ:IDXX) - September 1 at 8:33 AM logoVarian Medical Excels on Growing International Footprint (NASDAQ:IDXX) - August 31 at 10:23 AM
News IconStock Up Over the Past Five Trading Days: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Post News (NASDAQ:IDXX) - August 30 at 8:46 AM logoPrice Target For IDEXX Laboratories, Inc. (NASDAQ:IDXX) Set At $100.75 By Research Analysts - (NASDAQ:IDXX) - August 30 at 8:46 AM logoShares of IDXX Up 52.8% Since Uptrend Call on Shares (NASDAQ:IDXX) - August 26 at 5:25 PM logoAnalysts Estimate IDEXX Laboratories, Inc. (NASDAQ:IDXX) Will Achieve An EPS Growth Of 14% In Next 5 Years - (NASDAQ:IDXX) - August 22 at 5:38 PM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Reports Accounts Payable Of $50.085 - (NASDAQ:IDXX) - August 20 at 9:46 AM logoUptrend Call Working As Idexx Laboratories Stock Rises 54.4% (IDXX) (NASDAQ:IDXX) - August 19 at 8:32 AM logoIDEXX Investor Day (NASDAQ:IDXX) - August 17 at 5:47 PM logoBaron Funds Comments on IDEXX Laboratories (NASDAQ:IDXX) - August 17 at 5:47 PM
News IconTop Gainers of the Day: IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Diagnostic Substances (NASDAQ:IDXX) - August 17 at 8:39 AM logoIDEXX LABORATORIES INC /DE Financials (NASDAQ:IDXX) - August 9 at 5:45 PM logoIDEXX Laboratories to Host 2016 Investor Day (NASDAQ:IDXX) - August 8 at 5:46 PM logoCMCSA, IDXX, ZTS: Jim Cramer's Views (NASDAQ:IDXX) - August 8 at 10:16 AM
News IconHC Stocks Growth: Vertex Pharmaceuticals Incorporated (NASDAQ ... - share market updates (press release) (NASDAQ:IDXX) - August 6 at 8:26 AM logoETF’s with exposure to IDEXX Laboratories, Inc. : August 5, 2016 (NASDAQ:IDXX) - August 5 at 5:42 PM logoIdexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $6.5 million of Stocks - (NASDAQ:IDXX) - August 5 at 8:31 AM logoIdexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $6. ... (NASDAQ:IDXX) - August 5 at 8:31 AM logoHas IDEXX Labs Hit an Exhaustion Gap? (NASDAQ:IDXX) - August 4 at 5:52 PM logoIDEXX Laboratories Exceeds Expectations (NASDAQ:IDXX) - August 4 at 1:14 PM logoIDEXX Laboratories Inc. (IDXX) Soared To A New High On Q2 Results (NASDAQ:IDXX) - August 3 at 5:53 PM logoIDEXX Laboratories, Inc. :IDXX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:IDXX) - August 3 at 5:53 PM


Idexx Laboratories (NASDAQ:IDXX) Chart for Monday, September, 26, 2016

Last Updated on 9/26/2016 by Staff